Market Overview

Porphyria - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018-2020 - ResearchAndMarkets.com

Share:

The "Porphyria
- Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018"

drug pipelines has been added to ResearchAndMarkets.com's
offering.

Porphyria - Global API Manufacturers, Marketed and Phase III Drugs
Landscape, 2018 report provides comprehensive insights about marketed
and Phase III products for Porphyria. The report includes information of
marketed products including their product description, patent details,
forecasted sales till 2020 & API manufacturer details by country.

Coverage of API manufacturers for Porphyria marketed products spanning
across United States, Europe, China and India. The manufacturers'
details include manufacturers' name along with their location.

This report provides a comprehensive understanding of the emerging Phase
III therapies for Porphyria which can turn out to be future prospective
competitors for the marketed products. It will also put light on the
current market trends. Their forecasted global sales are also provided
till 2020.

Key Topics Covered:

1. Report Introduction

2. Porphyria: Overview

  • Risk Factors
  • Causes
  • Symptoms
  • Pathophysiology
  • Prognosis
  • Diagnosis
  • Treatment

3. Comparative Analysis of Marketed and Emerging Products

4. Marketed Therapies

  • Product Description
  • Route of Synthesis
  • Mechanism of Action
  • Pharmacology
  • Pharmacodynamics
  • Pharmacokinetics
  • Adverse Reactions
  • Clinical Trials
  • Regulatory Milestones
  • Product Development Activities

5. Emerging Therapies (Phase III)

  • Product Description
  • Research and Development
  • Product Development Activities

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/qv7zd4/porphyria?w=4

View Comments and Join the Discussion!